For instance, SNAC promotes oral absorption of Semaglutide in rats but not Liraglutide
Quarterly sales of Novo Nordisks Wegovy in 2022 and 2024, Statista (2024) Contrave, DailyMed (2024) Wegovy, DailyMed (2024) Prescription medications to treat overweight & obesity, National Institute of Diabetes and Digestive and Kidney Diseases (2024) Why obesity is a disease, Obesity Medicine Association (2023) AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity, Gastroenterology (2022) Naltrexone/bupropion ER (Contrave), Pharmacy & Therapeutics (2016) Once-weekly semaglutide in adults with overweight or obesity, New England Journal of Medicine (2021) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
It is also not recommended for people with a condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
For example, Ozempic, first approved in 2017 for type 2 diabetes, was so effective at reducing weight that it was approved specifically for obesity under the name Wegovy in 2021
However, some healthcare providers may consider prescribing both medications together off-label in select patients who have not achieved adequate weight loss with monotherapy